XML 47 R29.htm IDEA: XBRL DOCUMENT v3.22.4
Summary of Significant Accounting Policies (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended 24 Months Ended
Apr. 26, 2022
Dec. 03, 2021
Nov. 16, 2021
Dec. 06, 2019
Dec. 05, 2018
Apr. 30, 2022
Dec. 31, 2021
Sep. 30, 2022
Sep. 30, 2022
Dec. 31, 2021
Dec. 31, 2020
Sep. 18, 2017
Sep. 16, 2020
Jun. 30, 2022
Mar. 31, 2022
Proceeds from contract awards for research and development                     $ 845,820        
Payments to invoices in research and development           $ 791,017 $ 354,829 $ 282,643     436,188        
Net deficit on research and development                 $ 83,868 $ 1,021,808          
Financial liabilities fair value               0 0            
Allowance for doubtful accounts             $ 0     $ 0 $ 0        
Common Stock [Member]                              
Share price             $ 5.00     $ 5.00 $ 25.22     $ 6.00 $ 4.00
TCG Green Chem Inc [Member]                              
Payments to invoices in research and development                 450,000            
Project cost               1,500,000 1,500,000            
SBIR [Member]                              
Project cost             $ 1,527,185     $ 1,527,185 $ 505,377        
Research and Development Expense [Member]                              
Payments to invoices in research and development   $ 10,000 $ 1,411,883             82,467 412,321        
Phase II [Member]                              
Proceeds for research and development from collaborators                         $ 1,484,350    
Payments to invoices in research and development                 211,455            
Business development new establishment                   742,002          
Subcontract Phase II [Member]                              
Payments to invoices in research and development                 305,866 292,252          
1 Quarterly Payments [Member]                              
Proceeds from contract awards for research and development                     $ 211,455        
2 Quarterly Payments [Member]                              
Proceeds from contract awards for research and development                   $ 422,910          
Additional Funding Agreement Terms [Member]                              
Proceeds for research and development from collaborators       $ 795,248 $ 742,002             $ 299,502 $ 1,903,095    
Payments to invoices in research and development $ 211,455               791,017            
Research and development invoice receivable, outstanding               $ 4,231 $ 4,231